Thank you very much, Mr. Chair and witnesses.
I also want to thank the CCSA. When I first came on the health committee, I had an opportunity to be briefed by your organization. I got the chance to look at how you fit into the entire health system and how you can help to bring different groups and organizations together. I certainly appreciate it.
One of the things we're looking at now is the national framework for action. You've certainly discussed the First Do No Harm strategy. The national treatment strategy, I think, is also significant here.
But I'd like to focus on the third, which is the Canadian standards for youth drug prevention, and along with those, also on some of the information you've had. You spoke about cannabis use by youth in Canada—that's rather a tongue twister. One point was that youth are at particular risk for experiencing related harms, given their ongoing brain development and the significance associated with it. Also, you have this response in “Clearing the Smoke on Cannabis”, the series that is associated with that, in which you talk about chronic use and cognitive functioning and mental health, from the report that was done in that area.
I'd also point to the “Respiratory Effects of Cannabis Smoking”.
Then you are also talking about some of the upcoming research on cannabis and the brain.
I'm wondering whether you could put on the table some of the information you have there, so that we can take a look at this particular substance and get some of the real facts on it.